scholarly journals 343TiP Pembrolizumab (MK-3475) versus standard treatment in patients with recurrent or metastatic head and neck cancer: Methodology of phase 3 randomized trial

2015 ◽  
Vol 26 ◽  
pp. ix93
Author(s):  
J.-P. Machiels ◽  
S.W. Shin ◽  
E. Cohen ◽  
K. Harrington ◽  
B. Burtness ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Randomized Trial ◽  
Head And Neck ◽  
Neck Cancer ◽  
Standard Treatment ◽  
Phase 3

KEYNOTE-040: A phase III randomized trial of pembrolizumab (MK-3475) versus standard treatment in patients with recurrent or metastatic head and neck cancer.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. TPS6084-TPS6084 ◽  
Author(s):  
Ezra E. W. Cohen ◽  
Jean-Pascal H. Machiels ◽  
Kevin J. Harrington ◽  
Barbara Burtness ◽  
Sang Won Shin ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Randomized Trial ◽  
Head And Neck ◽  
Neck Cancer ◽  
Standard Treatment ◽  
Phase Iii

Randomized trial of standard pain control with or without gabapentin for pain related to radiation-induced mucositis in head and neck cancer

2016 ◽  
Vol 43 (6) ◽  
pp. 677-684 ◽  
Author(s):  
Tomoko Kataoka ◽  
Naomi Kiyota ◽  
Takanobu Shimada ◽  
Yohei Funakoshi ◽  
Naoko Chayahara ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Randomized Trial ◽  
Head And Neck ◽  
Neck Cancer ◽  
Pain Control ◽  
Radiation Induced

The EORTC randomized trial on three fractions per day and misonidazole (trial no. 22811) in advanced head and neck cancer: long-term results and side effects

1995 ◽  
Vol 35 (2) ◽  
pp. 91-99 ◽  
Author(s):  
Walter Van den Bogaert ◽  
Emmanuel van der Schueren ◽  
Jean-Claude Horiot ◽  
Mario De Vilhena ◽  
Simon Schraub ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Side Effects ◽  
Randomized Trial ◽  
Head And Neck ◽  
Neck Cancer ◽  
Long Term Results ◽  
Advanced Head
Sign in / Sign up

Export Citation Format

Share Document